Evidence method
Level · gp.fundamentals.debt_to_revenue
75.50% · OPTIONAL · NOT_ENOUGH_HISTORY
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
XERS · Dec 31, 2025
Xeris Biopharma Holdings, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0001867096-26-000016General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
9.81% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
43.72% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
23.53% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.operating_margin
8.53% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
10.68% · OPTIONAL · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
7.66% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History5 statesHistory building
Period transition
What moved in the state?
- Previous
- 295.06%
- Current
- 75.50%
- Delta
- -219.57%
- Previous
- 24.78%
- Current
- 9.81%
- Delta
- -14.97%
- Previous
- 37.06%
- Current
- 43.72%
- Delta
- 6.66%
- Previous
- 90.70%
- Current
- 23.53%
- Delta
- -67.17%
- Previous
- 9.05%
- Current
- 8.53%
- Delta
- -0.52%
- Previous
- 10.06%
- Current
- 10.68%
- Delta
- 0.62%
- Previous
- 10.28%
- Current
- 7.66%
- Delta
- -2.61%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · XERS Fundamental State →Has State · Xeris Biopharma Holdings, Inc. →Transitioned To · XERS Fundamental State →Transitioned To · XERS BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · XERS CASH_GENERATION_DECREASED →Transitioned To · XERS GROWTH_INCREASED →Transitioned To · XERS INVENTORY_PRESSURE_DECREASED →Transitioned To · XERS PROFITABILITY_DECREASED →Transitioned To · XERS R_AND_D_INTENSITY_INCREASED →Transitioned To · XERS SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.